Truist Financial’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.24M Sell
37,551
-15,483
-29% -$1.39M ﹤0.01% 1060
2025
Q4
$4.63M Sell
53,034
-56,425
-52% -$4.28M 0.01% 892
2025
Q3
$6.27M Sell
109,459
-1,908
-2% -$110K 0.01% 786
2025
Q2
$6.57M Sell
111,367
-396,951
-78% -$25.6M 0.01% 735
2025
Q1
$37.2M Buy
508,318
+439,693
+641% +$36.3M 0.06% 268
2024
Q4
$5.68M Buy
68,625
+563
+0.8% +$44.4K 0.01% 779
2024
Q3
$4.87M Sell
68,062
-1,842
-3% -$130K 0.01% 837
2024
Q2
$4.79M Sell
69,904
-15,171
-18% -$906K 0.01% 877
2024
Q1
$4.56M Buy
85,075
+4,291
+5% +$231K 0.01% 912
2023
Q4
$4.3M Buy
80,784
+7,140
+10% +$348K 0.01% 921
2023
Q3
$3.66M Buy
73,644
+4,378
+6% +$245K 0.01% 966
2023
Q2
$4.12M Sell
69,266
-361
-0.5% -$20.6K 0.01% 910
2023
Q1
$3.94M Sell
69,627
-72,412
-51% -$4.64M 0.01% 923
2022
Q4
$10.5M Buy
142,039
+35,092
+33% +$2.39M 0.02% 546
2022
Q3
$6.37M Sell
106,947
-2,528
-2% -$152K 0.01% 700
2022
Q2
$6.15M Buy
109,475
+29,387
+37% +$1.93M 0.01% 732
2022
Q1
$5.91M Buy
80,088
+5,621
+8% +$391K 0.01% 828
2021
Q4
$5.38M Buy
74,467
+361
+0.5% +$26.2K 0.01% 863
2021
Q3
$5.68M Buy
74,106
+13,267
+22% +$1.07M 0.01% 829
2021
Q2
$4.72M Buy
60,839
+1,600
+3% +$114K 0.01% 904
2021
Q1
$3.65M Buy
59,239
+3,130
+6% +$198K 0.01% 971
2020
Q4
$3.66M Buy
56,109
+587
+1% +$33.7K 0.01% 931
2020
Q3
$2.75M Sell
55,522
-14,569
-21% -$751K 0.01% 947
2020
Q2
$3.34M Sell
70,091
-89,180
-56% -$4.3M 0.01% 832
2020
Q1
$6.77M Buy
159,271
+2,127
+1% +$105K 0.02% 591
2019
Q4
$9.25M Buy
+157,144
New +$8.53M 0.02% 600
2015
Q3
Sell
-8,582
Closed -$220K 835
2015
Q2
$220K Buy
+8,582
New +$217K 0.01% 734

Other funds holding GMED